Tissue Expander Market Size, Share & Trends Analysis Report By Application  (Breast Reconstruction, Two-stage Breast Reconstruction, Single-stage Breast Reconstruction, Forehead Skin and Scalp Reconstruction, Face & Neck Reconstruction, Others), By Shape  (Anatomical, Round, Rectangular, Crescent, Others), By End-Use  (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Market Overview

The global tissue expander market size was valued at USD 669.42 million in 2022 and is projected to reach USD 1210.16 million by 2031, with a CAGR of 6.8 % during the forecast period 2023–2031. 

Tissue expanders are medical implants utilized in reconstructive cosmetic and trauma procedures. After implantation, they expand like a balloon to stretch the skin/tissue surrounding the implant. It is a hollow implant that is inserted under the skin during treatment for tissue expansion. A healthcare professional gradually fills the skin with carbon dioxide or saltwater through a self-sealing valve in order to stretch it and cause it to grow. In appearance, a tissue expander resembles a breast implant except that it has a thicker outer shell. There is a port on the expander's front panel. 

Tissue expander applications include Breast Reconstruction, Forehead Skin and Scalp Reconstruction, and Face & Neck Reconstruction. These implants are utilized in tissue expansion procedures for breast reconstruction, maxillofacial applications, and scalp reconstruction. It is most commonly used to regenerate the skin of adults and infants. Additionally, the procedure is used to treat burns, scars, and other congenital conditions. In 2020, according to the American Society of Plastic Surgeons, more than 102,250 breast reconstruction operations were performed, a 7% increase from the previous year.

Market Dynamics

Global Tissue Expander Market Drivers

A rise in the number of emergency cases and traffic accidents, which necessitate additional reconstructive procedures, as well as a growing preference for reconstructive surgery over skin implants and skin grafting procedures, are anticipated to stimulate the market. This industry is driven by the availability of sufficient healthcare technology to perform surgery in many regions.

The increase in the number of reconstruction surgeries performed is a significant factor in the expansion of the market. Tissue expansion is a surgical or restorative technique used to grow skin, bones, and other related issues. The prevalence of breast cancer has increased the demand for tissue-expanding procedures. The demand for tissue-expanding procedures to treat the legs, hands, and skin has increased in tandem with the development of technology to perform such procedures. The market for tissue expanders has been fueled by an increase in people's concern for their physical appearance.

In addition, The increase in breast cancer prevalence is also driving the expansion of the Tissue Expander Marker. According to the World Health Organization (WHO), 2,3 million women were diagnosed with breast cancer, and 685 000 women died in 2020. In addition, according to the WHO, factors such as advancing age, obesity, harmful alcohol consumption, family history of breast cancer, history of radiation exposure, reproductive history (such as age when menstruation began and age of first pregnancy), tobacco use, and postmenopausal hormone therapy increase the risk of breast cancer. Tissue expanders, after mastectomy, can be used for breast reconstruction, which is a surgical procedure to remove all breast tissue to treat breast cancer. The rising number of breast cancer cases is driving the growth of the market.

Global Tissue Expander Market Restraints

The application of a tissue expander requires a lengthy procedure. The technique necessitates the careful selection of the patient, meticulous planning, and flawless execution of the procedure, which typically lasts 8-12 weeks and consists of two surgical sessions. Any deviation from this procedure may result in unfavorable outcomes and complications, some of which are minor, and allow the procedure to be continued until the desired outcome is reached. In contrast, others, which are major, may result in abandonment of the procedure without achieving the desired outcome. In addition, tissue expanders are not readily available in developing nations. These factors hinder the expansion of the market for tissue expanders.

Global Tissue Expander Market Opportunities

Inflammation of tissues may be referred to as expansion. Seroma and infection are among the most common complications following implant-based reconstruction of the pre-pectoral region. The development of tissue expander technology that permits seroma aspiration via a combined drain port offers hope for improved clinical outcomes. Normal office-based aspiration of periprosthetic fluid through the combined drain port of the AlloX2 tissue expander not only permits successful aspiration of periprosthetic fluid but also enables transmission of aspirated liquid for culture, providing a lead-time advantage for initiation of targeted antibiotic therapy in cases of postoperative surgical site infection. In addition, the results demonstrate that positive bacterial cultures in the absence of clinical signs of infection do not warrant the administration of antibiotics. These kinds of technological advances in tissue expanders are expected to provide growth opportunities for the Market during the forecast period.

Regional Analysis

The global market for Tissue Expander has been segmented based on geography into North America, Europe, Asia Pacific, and LAMEA.

North America dominated the market with the largest revenue share, Due to its well-established healthcare infrastructure and rising healthcare expenditure. This region's growth is due to the high prevalence of breast cancer, which has increased the use of tissue expanders and foreskin restoration. The favorable government initiatives and the increasing number of research partnerships are propelling the growth of the North American Tissue Expander Market. In addition, the American Society of Plastic Surgeons reports that the greatest number of reconstructive surgeries were performed in the United States. Increased breast cancer incidence in Canada has contributed to this region's substantial revenue share.

Europe is anticipated to hold the second largest market share by 2031, 23.1%. This is a result of an increase in road accidents in Germany. Moreover, cosmetic procedures in the United Kingdom are on the rise, boosting regional market expansion. In addition, the increase in cosmetic surgeries in the United Kingdom contributes to the expansion of this regional market.

The Asia-Pacific region is expected to exhibit the highest growth rate over the forecast period due to an increase in the number of trauma cases and severe road accidents in India. They hold 38.2% of the total market share. Due to an increase in traffic accidents and trauma cases in countries such as India, the market for tissue expanders is projected to grow. In addition, China has one of the largest cosmetic industries in the world, with over 10,000 plastic surgery clinics, which is expected to increase the market for tissue expanders by 1.4X over the forecast period.

Segmental Analysis

The global Tissue Expander Market is segmented into Application, Shape, and End User.

The market is segmented by Application into Breast reconstruction, Forehead Skin, Scalp Reconstruction, Face & Neck Reconstruction, and Others.

Based on application, breast reconstruction had the biggest market share in 2021 and is expected to grow the fastest over the next few years. This is because more breast reconstruction surgeries are being done after mastectomy, which is a surgery that removes the breast. The American Society of Plastic Surgeons says that about 20% of women who have had a mastectomy choose to have reconstruction surgery.

Due to a rise in the number of these procedures, forehead skin and scalp reconstruction also brought in a lot of money in 2021. With a rise in trauma and burn cases and a high rate of cicatricial alopecia, there are more people who need scalp reduction surgeries. Having more face and neck reconstructions has also been helped by the fact that there are more products that can be used in these procedures. Also, tissue expansion surgeries on the face and neck tend to have fewer side effects than on other body parts.

The market is segmented by Shape into Anatomical, Round, Rectangular, Crescent, and Others.

 In 2021, anatomical products dominated the market in terms of shape, as they tend to offer a greater degree of projection than other expanders. Therefore, women undergoing breast reconstruction opt for anatomically shaped expanders to achieve a natural appearance.

Due to the fact that these products result in soft, round, and proportionally correct breasts, round-shaped expanders are anticipated to exhibit the highest CAGR during the forecast period. For instance, Sientra, Inc.'s Dermaspan is a circular or anatomically shaped tissue expander that helps achieve the desired shape of soft breasts. As they are commonly used in reconstructive surgeries involving the neck, face, arms, and legs, rectangular-shaped products are expected to experience substantial growth over the forecast period. These expanders are available with either silicone or saline filling. For instance, Groupe Sebbin's rectangular tissue expander is utilized in tissue augmentation procedures.

Significant contributions were made by crescent-shaped tissue expanders to the global tissue expanders market. These products are also used to reconstruct other body parts in addition to the breast. For example, Sientra, Inc.'s ACX is utilized for two-stage reconstruction.

The market is segmented by End-use into Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centers.

Based on end-use, hospitals generated the most market revenue in 2021. People prefer hospital settings because most reconstructive surgeries are performed in hospitals, allowing patients to choose from various options to improve their physical appearance

It is anticipated that cosmetology clinics will experience lucrative growth over the forecast period as women become increasingly concerned with their aesthetic appeal, particularly after mastectomy. In addition, the specific expertise provided by cosmetologists enables patients to evaluate the various reconstructive surgery options available.

Over the forecast period, ambulatory surgical centers are also anticipated to expand significantly. According to physicians, admission for the night following breast tissue expansion surgery is not required in all instances. Consequently, ambulatory surgical centers are considered an alternative setting for reconstructive procedures.

Impact of covid-19

The pandemic led to a temporary lockdown of the nations, which on a wide scale hindered the verticals of businesses and the industry. The automobile industry, which primarily involves outdoor jobs, has been poorly exposed to the challenges that have contributed to a dramatic decrease in car sales. Furthermore, the instability of the supply chain market mainly due to the closing of national and foreign borders and the adherence to the decision not to use Chinese produced products hampered the growth of the market. However, the considerable spike seen in the sale of the automotive vehicle to limit the usage of public and crowded places may positively affect the growth of the market in the upcoming years.

Recent Developments

• In October 2021, Establishment Labs Holdings Inc. announced the launch of JOYTM, an innovative breast aesthetics program centered on the patient.
• In September 2021, Establishment Labs Holdings Inc. held a symposium at the London Breast Meeting, signifying the official launch of the company's Motiva Flora tissue expander in Europe and additional CE Mark nations.
• In May 2021, Sientra, Inc. announced that Vizient, Inc. had awarded its AlloX2 tissue expander a contract for Innovative Technology.
• Blossom smart expander technology for breast reconstruction will be an innovative, rate-controlled, self-filling, pressure-responsive saline tissue expander (TE) system by 2020. This system will facilitate single-stage breast reconstruction procedures with a shorter duration to full expansion.
• In 2015, the AeroForm Tissue Expander System was utilized to expand soft tissues in breast reconstruction procedures. It is a temporary measure that cannot exceed six months.